Sue Chetwin: Pharmac Panel Review chair says concerns around agency's transparency, equity

Pharmac is potentially a good model, but there are issues. A panel reviewing the drug buying agency has released its interim report on its operation. Review chair Sue Chetwin says told Heather du Plessis-Allan Pharmac's under increasing challenges from consumers, patient advocates and clinicians.  She said the big concerns are mostly the same from everyone.  They’re all around access to medicine, the timing of medicines, the transparency of how Pharmac actually operates and, very importantly, equity issues.” A final report is due at the end of February, with recommendations. LISTEN ABOVESee omnystudio.com/listener for privacy information.